Friday, February 09, 2018 5:20:41 PM
But I strongly suspect Scandium revenues will come in much higher than projected. The average projected price for Scandium is $3,675 per kg over 32yr mine life. But the highest purity levels sell for much higher prices. I suspect when all sales are averaged in, the "all in price average" will be $4,500 to $5,000 per kg.
Now it costs $1,127 to produce 1 kg of Scandium according to FS estimates.
Which means only $2,548 goes to EBITDA. But if the all-in-pricing-average is $4,949 ( increase of 50% of $2,548) then all of the additional $1,274 per kg goes directly to EBITDA, because there is no additional overhead whatsoever. Approximately $131 million increase in pretax. 389+131= $520 million EBITDA.
There is currently about 100 million in capex water costs and 11 million in operational water costs. They won't drop to zero but will probably see serious reductions. Another big bump to EBITDA.
Also remember the current structure is scalable. Niocorp could increase production up to 50% after operations begin and if the market demands increased supply. Another HUGE increase to EBITDA!! I suspect the demand for Scandium will be much stronger than the current conservative forecasts. Thousands of new patents for Scandium awaiting a reliable quality supplier!
Plus Niocorp will most likely participate in revenues from patents on Scandium Alloys with IBC.
This is all very important to the amount of dividends that WILL BE PAID!!!
Mark Smith has always been very clear that he will pay dividends as soon as possible!!
Food for thought!!!
Recent NB News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 04:28:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 10:02:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 10:01:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 10:01:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 10:00:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 10:00:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/22/2023 09:00:27 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 12/21/2023 09:45:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 09:55:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/17/2023 09:30:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/17/2023 09:30:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/17/2023 09:30:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 12:30:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2023 09:01:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 12:30:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2023 12:30:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:30:22 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM